Cancer BiologyJournal of Experimental & Clinical Cancer ResearchPeer-reviewed
Ligand-independent c-Met activation by HHLA2 drives hepatocellular carcinoma and predicts c-MET inhibitor efficacy
Xubo Huang, Runya Fang, Yuqian Pang…·Yongjie Wei
This study identifies HHLA2 as a ligand-independent activator of c-Met in HCC, showing its role in tumor progression and its predictive value for c-Met inhibitor response.
4 citations